Related Experiment Video
Updated: Apr 17, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options
Cecilia Söderberg-Nauclér1, John Inge Johnsen1
1Cecilia Söderberg-Nauclér, Experimental Cardiovascular Research Unit, Department of Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Abstract:
During the last years increasing evidence implies that human cytomegalovirus (CMV) can be attributed to human malignancies arising from numerous tissues. In this perspective, we will review and discuss the potential mechanisms through which CMV infection may contribute to brain tumors by affecting tumor cell initiation, progression and metastasis formation. Recent evidence also suggests that anti-CMV treatment results in impaired tumor growth of CMV positive xenografts in animal models and potentially increased survival in CMV positive glioblastoma patients. Based on these observations and the high tumor promoting capacity of this virus, the classical and novel antiviral therapies against CMV should be revisited as they may represent a great promise for halting tumor progression and lower cancer deaths.
Insights
Human cytomegalovirus (CMV) may drive brain tumor development and progression. Revisiting antiviral therapies against CMV shows promise for halting cancer growth and reducing mortality.
Area of Science:
- Oncology
- Virology
- Neuro-oncology
Background:
- Increasing evidence links human cytomegalovirus (CMV) to various human malignancies.
- CMV infection is implicated in the initiation, progression, and metastasis of brain tumors.
Purpose of the Study:
- To review and discuss the mechanisms by which CMV contributes to brain tumor development.
- To explore the potential of anti-CMV therapies in managing brain cancers.
Main Methods:
- Literature review and discussion of existing evidence on CMV and brain tumors.
- Analysis of preclinical data from CMV-positive xenografts.
- Review of clinical observations in CMV-positive glioblastoma patients.
Main Results:
- CMV infection may influence brain tumor initiation, progression, and metastasis.
- Anti-CMV treatment demonstrated impaired tumor growth in animal models.
- Potential for increased survival in CMV-positive glioblastoma patients receiving anti-CMV treatment.
Conclusions:
- CMV possesses significant tumor-promoting capabilities, particularly in brain tumors.
- Antiviral therapies targeting CMV warrant further investigation as a potential cancer treatment strategy.
- Revisiting CMV antiviral therapies could offer a promising approach to reduce cancer progression and mortality.
Related Concept Videos
Cytomegalovirus Disease
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Viral Meningitis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

